Reclast Associated with Lower Risk of Fractures: Risk of Kidney Failure Remains

Share Article

A new study published in the November 1st 2012 issue of the New England Journal of Medicine reveals that Reclast (zoledronic acid) was associated with a significantly reduced risk of vertebral fracture among men with osteoporosis. Reclast is the brand name for zoledronic acid, a medication that is used to treat pre-osteoporosis conditions in both men and women. Manufactured by Novartis, it was approved by the FDA in June 2007. In September 2011, the FDA issued an update to the drug label for Reclast to better inform of the risk of kidney failure. Now, AttorneyOne.com, a recognized authority on law, can provide helpful, proven advice and simple solutions including how to get in contact with legal counsel so anyone can easily and inexpensively deal with cases of Reclast severe adverse events. http://www.attorneyone.com/reclast-lawsuit/

Reclast: severe adverse events threat

Reclast: severe adverse events threat

FDA issued an update to the drug label for Reclast to better inform of the risk of kidney failure

The media spotlight is often a double-edged sword. No one knows this better than people who suffer from Reclast side effects. And yet, gossip and rumor-mongering aside, the real story here is being overlooked according to Sean Burke of AttorneyOne.

A new study published in the November 1st, 2012 issue of the New England Journal of Medicine reveals that Reclast (zoledronic acid) was associated with a significantly reduced risk of vertebral fracture among men with osteoporosis. Reclast is the brand name for zoledronic acid, a medication that is used to treat pre-osteoporosis conditions in both men and women.

Manufactured by Novartis, it was approved by the FDA in June 2007 for use as a one-time, yearly treatment to be given by injection on an annual basis. In September 2011, the FDA issued an update to the drug label for Reclast to better inform of the risk of kidney failure. Kidney failure is a rare, but serious, side effect associated with the use of Reclast.

AttorneyOne.com, a recognized authority on law, can provide helpful advice and simple solutions including how to get in contact with legal counsel so that, in case of severe adverse events from Reclast, someone can easily and inexpensively deal with it. As Mr. Burke, director of Media Relations for AttorneyOne.com, added, “What all this information really illustrates is that alleged threat from Reclast remains. For that reason, our focus should squarely fall on getting the word out and assisting people in finding the right legal assistance.”

A January 2009 FDA post-market safety review identified five deaths from acute renal failure following Reclast infusion.

AttorneyOne.com has further information on Reclast lawsuits including how to get in contact with legal counsel.

Headquartered in San Diego, CA Attorney One was founded in 2004 and is not a law firm. They offer a nationwide legal service which helps consumers find the best representation for their legal needs. You can learn more about Attorney One at our website http://www.attorneyone.com. You can also find us on Facebook at http://www.facebook.com/AttorneyOne. Checkout earlier news from us at http://www.prweb.com/releases/2012/11/prweb10163796.htm.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Sean Burke
Visit website